Bridgewater Associates, founded by Ray Dalio, significantly cut its investment in automated test equipment supplier Teradyne (TER), reducing its position by over 70% during the second quarter of 2026. The firm's stake fell from 338.95K shares to 98.63K shares, with the reported value dropping from over $100 million to approximately $47.7 million. This trade information was disclosed in a quarterly 13F filing with the SEC on August 14, 2026, reflecting trades made in the prior quarter ending June 30.
Teradyne supplies testing equipment and robotics for the semiconductor and electronics industries. The company reported record revenue and earnings for the second quarter, citing strong demand driven by artificial intelligence for both semiconductor and memory testing. Despite the company's strong performance and optimistic outlook provided in late July, Bridgewater's move represents a substantial reduction in its exposure.